Identifying Opportunities In A Dynamic Market: Complementary Research on Transgenomic, TriMas, Trimble, U.S. Concrete and UFP Technologies

NEW YORK, December 26, 2014 /PRNewswire/ --

Moments ago, Analysts Review released new research updates concerning several important developing situations including Transgenomic (NASDAQ: TBIO), TriMas (NASDAQ: TRS), Trimble (NASDAQ: TRMB), U.S. Concrete (NASDAQ: USCR), and UFP Technologies (NASDAQ: UFPT). Analysts Review provides a single unified platform for investors' to hear about what matters - proudly employing registered CFA® research staff and rigorous compliance procedures. The full research reports are being made available to the public for informational purposes only.

To access our full PDF reports on a complementary basis, please visit the links below.

--

Today's update concerns the following companies:

============

Full PDF Download Links (you may have to copy and paste the following links into your browser):

TBIO Research Report: ( http://get.analystsreview.com/pdf/?c=Transgenomic&d=26-Dec-2014&s=TBIO ),

TRS Research Report: ( http://get.analystsreview.com/pdf/?c=TriMas&d=26-Dec-2014&s=TRS ),

TRMB Research Report: ( http://get.analystsreview.com/pdf/?c=Trimble&d=26-Dec-2014&s=TRMB ),

USCR Research Report: ( http://get.analystsreview.com/pdf/?c=U.S.%20Concrete&d=26-Dec-2014&s=USCR ),

UFPT Research Report: ( http://get.analystsreview.com/pdf/?c=UFP%20Technologies&d=26-Dec-2014&s=UFPT ).

============

--

Analyst Update: Collaborations, Spin-Offs, Product Launch, Acquisition and Financial Results

Reviewed by: Rohit Tuli, CFA®  

The U.S. markets on Wednesday ended mostly higher as a steeper-than-expected drop in the weekly jobless claims kept the investors' mood positive. The number of people who applied for U.S. unemployment-insurance benefits declined by 9,000 to 280,000 in the week ended December 20, 2014, a seven-week low and only modestly above a 14-year low. During the session, the Dow Jones Industrial Average gained 0.03%, S&P 500 declined 0.01%, and the Nasdaq Composite advanced 0.17%. The European market ended the session on a mixed note as data of British workers' productivity highlighted a long-awaited improvement in the third quarter of this year, highlighting how Britain has managed to avoid the worst of the economic slump afflicting the euro zone. The Asian markets too ended mixed following a sharp run-up in recent days as strong U.S. data propelled Wall Street stocks to record highs. The investors are also keeping a close watch on the Japanese government's effort to support the still-fragile economic recovery in the near term.

Transgenomic, Inc. (Transgenomic) has collaborated with Tuberous Sclerosis Alliance (TS Alliance) to share genetic variants Information from its Tuberous Sclerosis Complex (TSC) Tests to the

TSC Variant Databasein Database.  The Collaboration aims to improve researchers understanding of genetic disease tuberous sclerosis.

TriMas Corporation's (TriMas) board has ratified a plan to trail a tax-free spin-off of 100% of its Cequent businesses into a new stand-alone, publicly traded company. Upon completion of the transaction (which is expected during mid-2015), the new stand-alone Cequent company will consist of TriMas' current Cequent Americas and Cequent APEA segments, with a combined annual revenue of $614 million for the trailing 12 month period ended September 30, 2014.

Trimble Navigation Limited (Trimble), provider of technology solutions has launched a new version of its Trimble Quantm version 8 system for road and rail alignment planning. Quantm version 8 produces accurate geometric alignments that can be used in the design and construction phases of a project.

U.S. Concrete, Inc. (U S Concrete) has completed the acquisition of the Ready-Mixed concrete assets and property of Diamond Concrete, Inc. on Staten Island, New York. The acquisition includes one ready-mixed concrete facility and related real estate, along with 24 ready-mixed concrete trucks.

Manufacturer of packaging and component products, UFP Technologies, Inc. (UFP Technologies) reported modest sales growth for its third quarter 2014 as the Company sustained its medical market growth and an improvement in military orders helped offset a decline its automotive market.

--

About Analysts Review  

At Analysts Review, we provide our members with a simple and reliable way to leverage our economy of scale. Most investors do not have time to track all publicly traded companies, much less perform an in-depth review and analysis of the complexities contained in each situation. That's where Analysts Review comes in. We provide a single unified platform for investors' to hear about what matters. Situation alerts, moving events, and upcoming opportunities.

Analysts Review was designed for investors. By providing the best information available, we have set ourselves apart as one of the premier online investor communities.

--

Editor Note: This is not company news. We are an independent source and our views do not reflect the companies mentioned.

Compliance Procedure: Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review, represented by Rohit Tuli, CFA®. An outsourced research services provider has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

Further Resources: For more information about this release including editorial notes, compliance procedures and legal disclosures, please visit: http://www.analystsreview.com/editors

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE Analysts Review

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED